Nancy L. Samberg

465 total citations
15 papers, 163 citations indexed

About

Nancy L. Samberg is a scholar working on Immunology, Oncology and Biotechnology. According to data from OpenAlex, Nancy L. Samberg has authored 15 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 4 papers in Biotechnology. Recurrent topics in Nancy L. Samberg's work include CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (5 papers). Nancy L. Samberg is often cited by papers focused on CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (5 papers). Nancy L. Samberg collaborates with scholars based in United States, United Kingdom and France. Nancy L. Samberg's co-authors include Hans J. Stauss, Alan Landay, Lawrence A. Potempa, Robert A. Bray, H Gewurz, Víctor Moreno, Patrick Schöffski, Jan M. Van Tornout, David Olmos and Fei Jie and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Nancy L. Samberg

14 papers receiving 160 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy L. Samberg United States 7 72 66 35 30 23 15 163
Consuelo López Spain 5 108 1.5× 49 0.7× 41 1.2× 31 1.0× 15 0.7× 9 229
Zhengping Wei China 8 90 1.3× 87 1.3× 25 0.7× 49 1.6× 33 1.4× 11 212
Joseph D. P. Willet United Kingdom 6 79 1.1× 48 0.7× 15 0.4× 36 1.2× 11 0.5× 7 146
Jason Perera United States 6 155 2.2× 38 0.6× 11 0.3× 37 1.2× 19 0.8× 10 235
Ricardo P. Moura Brazil 8 28 0.4× 94 1.4× 13 0.4× 38 1.3× 29 1.3× 10 184
Mara Epstein United States 4 31 0.4× 59 0.9× 54 1.5× 78 2.6× 49 2.1× 5 181
Stefanie Kreutmair Germany 9 40 0.6× 88 1.3× 24 0.7× 49 1.6× 13 0.6× 21 173
Giacomo Tampella Italy 7 118 1.6× 20 0.3× 14 0.4× 12 0.4× 14 0.6× 13 159
Christopher Paluch United Kingdom 4 133 1.8× 57 0.9× 8 0.2× 81 2.7× 13 0.6× 5 203
R. Dummer Switzerland 5 108 1.5× 60 0.9× 13 0.4× 190 6.3× 36 1.6× 17 239

Countries citing papers authored by Nancy L. Samberg

Since Specialization
Citations

This map shows the geographic impact of Nancy L. Samberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy L. Samberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy L. Samberg more than expected).

Fields of papers citing papers by Nancy L. Samberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy L. Samberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy L. Samberg. The network helps show where Nancy L. Samberg may publish in the future.

Co-authorship network of co-authors of Nancy L. Samberg

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy L. Samberg. A scholar is included among the top collaborators of Nancy L. Samberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy L. Samberg. Nancy L. Samberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Sarnaik, Amod, Brendan D. Curti, Diwakar Davar, et al.. (2018). A phase 2, multicenter study to assess the efficacy and safety of autologous tumor-infiltrating lymphocytes (LN-144) for the treatment of patients with metastatic melanoma.. Journal of Clinical Oncology. 36(15_suppl). TPS9595–TPS9595. 2 indexed citations
3.
4.
Sarnaik, Amod A., Brendan D. Curti, Diwakar Davar, et al.. (2018). Abstract CT169: A phase II, multicenter study to assess the efficacy and safety of autologous tumor infiltrating lymphocytes (LN-144) for treatment of patients with metastatic melanoma. Cancer Research. 78(13_Supplement). CT169–CT169. 1 indexed citations
5.
Mateo, Joaquı́n, David Olmos, Herlinde Dumez, et al.. (2016). A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies. British Journal of Cancer. 114(8). 889–896. 48 indexed citations
6.
Zhu, Tong, James J. Keirns, Atsunori Kaibara, et al.. (2016). Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T‐Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients. Clinical Pharmacology in Drug Development. 5(5). 408–425. 1 indexed citations
7.
Zhang, Wenhui, Erik E. Karrer, Stanley Cohen, et al.. (2015). A Phase 1 Dose‐Escalation Study of ASP2409, a Selective T‐Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy. Clinical Pharmacology in Drug Development. 5(4). 259–268. 3 indexed citations
8.
Mateo, Joaquı́n, Patrick Schöffski, David Olmos, et al.. (2013). Abstract B187: Pharmacodynamics of OSI-027, a dual mTORC1/mTORC2 inhibitor, in tumor and surrogate tissues: Results from the expansion phase of a first-in-man study.. Molecular Cancer Therapeutics. 12(11_Supplement). B187–B187. 1 indexed citations
9.
10.
Marvel, Jacqueline, et al.. (1991). The CD45RA molecule is expressed in naive murine CTL precursors but absent in memory and effector CTL. International Immunology. 3(1). 21–28. 12 indexed citations
11.
Samberg, Nancy L., et al.. (1989). The α3 domain of major histocompatibility complex class I molecules plays a critical role in cytotoxic T lymphocyte stimulation. European Journal of Immunology. 19(12). 2349–2354. 29 indexed citations
12.
Bray, Robert A., Nancy L. Samberg, H Gewurz, Lawrence A. Potempa, & Alan Landay. (1988). C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.. The Journal of Immunology. 140(12). 4271–4278. 21 indexed citations
13.
Samberg, Nancy L., Robert A. Bray, H Gewurz, Alan Landay, & Lawrence A. Potempa. (1988). Preferential expression of neo-CRP epitopes on the surface of human peripheral blood lymphocytes. Cellular Immunology. 116(1). 86–98. 22 indexed citations
14.
Bray, Robert A., Nancy L. Samberg, Alan Landay, H Gewurz, & Lawrence A. Potempa. (1987). Identification of a novel antigenic specificity present on the surface of human natural killer cells and B lymphocytes. Clinical Immunology Newsletter. 8(9). 137–140. 6 indexed citations
15.
Samberg, Nancy L., et al.. (1984). Comparison of three serologic techniques for detection of antibody to Mycoplasma pulmonis.. PubMed. 74(1). 21–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Consuelo López Breakdown of academic impact, for papers by Zhengping Wei Breakdown of academic impact, for papers by Joseph D. P. Willet Breakdown of academic impact, for papers by Jason Perera Breakdown of academic impact, for papers by Ricardo P. Moura Breakdown of academic impact, for papers by Mara Epstein Breakdown of academic impact, for papers by Stefanie Kreutmair Breakdown of academic impact, for papers by Giacomo Tampella Breakdown of academic impact, for papers by Christopher Paluch Breakdown of academic impact, for papers by R. Dummer
Rankless by CCL
2026